Happy International Women's Day to all the women in the field of cellular therapy and transplantation, who save lives every day. You are our heroes! #InternationalWomensDay #InspireInclusion

1/x Much awaited BMT CTN 1506 trial out in Journal of Clinical Oncology establishing gilteritinib as SOC post #alloBMT maintenance in #MRD +ve FLT3-ITD #AML pts in CR1; thanks to a global collaboration funded by Astellas Pharma US NIH NHLBI and National Cancer Institute to BMT CTN tweetorial👇 ascopubs.org/doi/pdf/10.120…

Proud of the effort led by Ola Oluwele Mehdi Hamadani, MD and colleagues of the ASTCT cell therapy and practice guidelines committees presenting an expert opinion on outpatient CAR-T therapies. #tcellrx #immunotherapy

The FDA Adverse Event Reporting System reported secondary primary malignancies in 4.3% of patients who received CAR T-cell therapies. #hematology #medtwitter | Magdi Elsallab, MD, PhD Matt Lunning D.O. Christopher D'Angelo Miguel Perales M.D. Matthew Frigault Dr Marcela Maus cancernetwork.com/view/evaluatin…

NEW CME Opportunity ✨ Read the latest ASTCT Practice Guidelines, take a comprehension quiz & earn CME! 3 articles will be available, 2 of which are now online. This free continuing education activity should take around 1 hour & is eligible for 1 CME. ow.ly/v5zw50QTJ3g

ICYMI: The 2024 Request for Information (RFI) forms are now available on the ASTCT website. These forms are developed by a dedicated committee and reviewed by many insurance companies and managed care organizations. View the forms: ow.ly/voLu50QM2bu

Fundamentals of HCT training course with $15 USD registration rate for persons from LMICs. Kudos to ASTCT for this effort towards global equity in #BMTsm and #CARTcells education. astct.org/Attend/Fundame…

Every day, we move closer to realizing Memorial Sloan Kettering Cancer Center's mission of ending cancer for life. It happens one patient & one life-changing discovery at a time. Fueled by the innovation & compassion of our staff, it’s a mission driven by our ambition and collective hope that... 🧵👇

Infections are the 2nd most common cause of non-cancer mortailty during cancer treatment. Vaccine preventable illnesses like flu and pneumonias pose the greatest risk. Shingles is debilitating ASCO vaccine guidelines summary 👇Amar Kelkar, MD, MPH, FACP. Key point #vaccinate always and early

Congrats to Diane Reidy-Lagunes and the “Cancer Straight Talk” podcast from Memorial Sloan Kettering Cancer Center team for winning the 2024 Gracie Grand Award and the Award for Best Educational Podcast, an honor that recognizes their significant achievements! bit.ly/3IWQaeb AWM Headquarters

🚨 hot off the press 🚨 A (perhaps) underestimated aspect of CAR T-cell therapy: non-relapse mortality. Check out our new meta-analysis on this clinically relevant topic - out today in Nature Medicine ! nature.com/articles/s4159… Let’s take a deeper dive! Start 🧵

Just out Nature Medicine meta-analysis >7600 CAR T pts led by David Cordas dos Santos & Kai Rejeski - Non-relapse mortality post CAR-T = 6.8% - highest w ciltacel (15%) & brexucel (10.6%) - axicel (7%) > tisa-/lisocel (4%) for LBCL - 51% of NRM deaths from infection nature.com/articles/s4159…

It was a pleasure discussing some of the clinical implications of our recent Nature Medicine publication on CAR-T related NRM in a Q&A with Memorial Sloan Kettering Cancer Center 👇 #nrm #infections #spm #cartsm #lymsm #mmsm Roni Shouval Miguel Perales M.D. mskcc.org/clinical-updat…

Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma ow.ly/2i1Z50SFwC6 #clinicaltrialsandobservations #immunobiologyandimmunotherapy #lymphoidneoplasia

Healio spoke with Miguel Perales M.D. and Kai Rejeski about study findings showing that infections are the primary cause of nonrelapse mortality among individuals who undergo chimeric antigen receptor T-cell therapy. #CART Memorial Sloan Kettering Cancer Center Read more👇 healio.com/news/hematolog…

Miguel Perales M.D. ASTCT Memorial Sloan Kettering Cancer Center thanks, as always for coming to our SBTMO meeting & sharing your knowledge with us! Amazing lecture about complications after CAR T :-) look for the QR code at Liang et al BMT 2024 & for the ASTCT Best practice paper coming soon❤️❤️🔝🔝

SBTMO meeting & ASTCT ! Thank you for coming to our meeting & sharing your knowledge with us! Miguel Perales M.D. Sergio Giralt Akshay Sharma MD @akshaysharma.bsky.social Marcelo Pasquini Marcos de Lima Nelson Chao, Mary Flowers, Paul Carpenter, Amin Alousi, Andrew Artz and Anna Hawkhead🔝🔝

come join us at the non-malignant heme symposium! Register today! bit.ly/NonMalignantHe… #TCT4nonmalignant2024 Memorial Sloan Kettering Cancer Center MSK CME

The GSK Graduate School at Memorial Sloan Kettering Cancer Center is now accepting applications for its Cancer Biology and Cancer Engineering programs for the 2025 year. Apply here: bit.ly/3YWHT39